Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 4—April 2016
Synopsis

Shiga Toxin–Producing Escherichia coli O157, England and Wales, 1983–2012

Natalie L. AdamsComments to Author , Lisa Byrne, Geraldine A. Smith, Richard Elson, John P. Harris, Roland Salmon, Robert Smith, Sarah J. O’Brien, Goutam K. Adak, and Claire Jenkins
Author affiliations: Public Health England, London, UK (N.L. Adams, L. Byrne, G.A. Smith, R. Elson, J.P. Harris, G.K. Adak, C. Jenkins); National Institute for Health Research Health Protection Research Unit in Gastrointestinal Infections, Liverpool, UK (N.L. Adams, J.P. Harris, S.J. O’Brien, G.K. Adak); National Institute for Health Research Health Protection Research Unit in Gastrointestinal Infections, Colindale, UK (N.L. Adams, G.K. Adak, C. Jenkins); Public Health Wales, Cardiff, UK (R. Salmon, R. Smith)

Main Article

Figure 3

Crude incidence (cases per 100,000 person-years) of Shiga toxin–producing Escherichia coli O157, by patient age group and sex, England and Wales, 1997–2012. Error bars indicate 95% CIs.

Figure 3. Crude incidence (cases per 100,000 person-years) of Shiga toxin–producing Escherichia coli O157, by patient age group and sex, England and Wales, 1997–2012. Error bars indicate 95% CIs.

Main Article

Page created: March 15, 2016
Page updated: March 15, 2016
Page reviewed: March 15, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external